JOURNEY™ II CR Total Knee System
← catalyst calendarNCT02440672 · readout ≤ 681 d
Sponsored by Smith & Nephew, Inc. (industry) · SNN — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
170actual
Sites
9
Countries
Spain, United Kingdom, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Sep 2015 | not stated | When the study began enrolling |
| Primary completion | Jun 2028 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2015-05-12 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-12 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Osteoarthritis, Knee
Intervention
- Device: JOURNEY™ II CR Total Knee System (J II CR TKS) — also filed as JOURNEY™ II CR, (J II CR TKS)
Primary outcomes
what the primary-completion date above is the date OFEquivalence in 1 year post-operative mean Range of Motion (ROM) in subjects receiving the J II CR TKS as compared to the literature reference mean ROM
measured 1 year post-op analysis
Non-inferiority of the survival rate of the J II CR TKS with the reference survival rate of a literature reference at 5 and 10-years post-operatively
measured Up to 10 year post-operative analysis
Permalink · SNN's whole pipeline · Catalyst calendar · Every registered study · What changed